The patient experienced significant decreases in FGF23, normalization of blood phosphate levels, and a profound reduction in tumor burden while on therapy.(19) Remarkably, pretreatment and posttreatment biopsies of PMT metastases showed evidence of infigratinib‐induced differentiation of the PMT into mature lamellar bone. Here, FGF23 is linked to neoplasm.